Financial reports
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
21 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
16 Mar 22
10-Q
2021 Q3
Quarterly report
9 Nov 21
Current reports
8-K
Departure of Directors or Certain Officers
14 Sep 23
8-K
Submission of Matters to a Vote of Security Holders
9 Jun 23
8-K
Departure of Directors or Certain Officers
25 Apr 23
8-K
Departure of Directors or Certain Officers
12 Apr 23
8-K
Departure of Directors or Certain Officers
10 Mar 23
8-K
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
15 Nov 22
8-K
Departure of Directors or Certain Officers
22 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
10 Jun 22
8-K
Entry into a Material Definitive Agreement
30 Mar 22
8-K
Entry into a Material Definitive Agreement
18 Feb 22
Registration and prospectus
S-8
Registration of securities for employees
28 Mar 24
S-3
Shelf registration
9 May 23
S-8
Registration of securities for employees
21 Mar 23
424B7
Prospectus with selling stockholder info
30 Dec 22
424B3
Prospectus supplement
15 Dec 22
S-3
Shelf registration
6 Dec 22
D
$30.00 mm in equity / options / securities to be acquired, sold $30.00 mm, 64 investors
21 Nov 22
S-8
Registration of securities for employees
16 Mar 22
424B5
Prospectus supplement for primary offering
1 Oct 21
424B5
Prospectus supplement for primary offering
1 Oct 21
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
26 Apr 21
DEF 14A
Definitive proxy
26 Apr 21
DEFA14A
Additional proxy soliciting materials
29 May 20
DEF 14A
Definitive proxy
29 May 20
PRE 14A
Preliminary proxy
15 May 20
DEFA14A
Additional proxy soliciting materials
18 Jun 19
Other
EFFECT
Notice of effectiveness
30 May 23
CORRESP
Correspondence with SEC
24 May 23
UPLOAD
Letter from SEC
16 May 23
EFFECT
Notice of effectiveness
15 Dec 22
CORRESP
Correspondence with SEC
12 Dec 22
UPLOAD
Letter from SEC
9 Dec 22
EFFECT
Notice of effectiveness
24 May 21
UPLOAD
Letter from SEC
31 Jul 19
CORRESP
Correspondence with SEC
9 Jul 19
UPLOAD
Letter from SEC
3 Jul 19